Silo Wellness to Host Psychedelic Retreat Exclusively for LGBTQIA+ Community
In honor of Pride Month, Silo Wellness is launching its first-ever LGBTQIA+ psychedelic retreat in Jamaica.
In honor of Pride Month, Silo Wellness is launching its first-ever LGBTQIA+ psychedelic retreat in Jamaica.
In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.
This week in psychedelic business news: Therapeutic uses of salvinorin A, a 5-MeO-DMT retreat, and World Boxing Council explores psychedelics.
New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a clinical setting.
Daniel Carcillo’s psychedelic life sciences company is now trading on the Canadian Securities Exchange.
For Trauma Awareness Month the online platform Psychable is promoting psychedelic-assisted therapy for treating a number of conditions.
DMT-focused psychedelic therapy company Small Pharma is listing on the Canadian TSK Venture Exchange as it ramps up its offerings.
Spravato, the ketamine-based therapy produced by Johnson & Johnson, is now legal to use as therapy for depression in Singapore.
The psychedelic investment platform Clarify Pharma is expecting to go public on the AQSE with a valuation of £10.5 million.
Advocate and activist Ashley Lukens has her reasons for supporting psychedelic medicine. They helped her battle cancer. Now she’s returning the favor.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.